Moors & Cabot’s Stryker SYK Stock Holding History

Moors & Cabot’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$4.31K	–	935
2024 Q1	$4.31K	Buy	+100	New	+$33.6K	﹤0.01%	896

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Moors & Cabot's SYK Position: Q2 2026 in Review

Moors & Cabot reduced its Stryker (SYK) stake by 9.3% in Q2 2026, selling an estimated $289K and leaving 8,985 shares worth $2.83M. The position accounts for 0.11% of the portfolio, ranked #176.

Moors & Cabot first reported a position in SYK in Q1 2014 and has held it in 50 quarters since. The position peaked at $5.05M in Q4 2019. 2,263 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

Moors & Cabot held 8,985 shares of Stryker worth $2.83M as of Q2 2026.
Moors & Cabot sold 917 Stryker shares in Q2 2026, an estimated $289K.
Stryker made up 0.11% of Moors & Cabot's portfolio in Q2 2026, its #176 holding.
Moors & Cabot first reported a position in Stryker in Q1 2014 and has held it in 50 quarters since.
Moors & Cabot's Stryker position peaked at $5.05M in Q4 2019.
2,263 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.